Aims: This study examined the anxiety levels of nurses and nurse candidates regarding humanoid nurse robots and artificial intelligence health technologies in perioperative patient care.
Design: Descriptive and cross-sectional study.
Methods: The research was conducted with 158 intern students and 167 surgical nurses. Socio-demographic characteristics form, Questions Form Regarding Humanoid Nurse Robots and Artificial Intelligence Health Technologies, Artificial Intelligence Anxiety Scale and The Medical Artificial Intelligence Preparedness Scale were used. The independent t-test and one-way analysis of variance (ANOVA) were used. This study complied with Appendix S1.
Results: The total scores on the Artificial Intelligence Anxiety Scale for nurses and nursing students are 73.089 ± 31.667 and 73.624 ± 28.029, respectively. The total scores on the Artificial Intelligence Readiness Scale for nurses and nursing students are 71.736 ± 15.064 and 72.183 ± 13.714, respectively. When comparing the sociodemographic characteristics and scale scores of nurses, a statistically significant difference was found between age and the Artificial Intelligence Anxiety Scale scores (p < 0.05). There was also a statistically significant difference between age, gender and work duration and the Artificial Intelligence Readiness Scale scores for nurses (p < 0.05).
Conclusion: Both groups exhibited moderate levels of anxiety and readiness regarding artificial intelligence. Comprehensive research is needed to elucidate the impact of artificial intelligence technologies on nursing professionals.
Implication For The Profession: The proper use of Artificial Intelligence technologies can enhance the quality of patient care, alleviate the workload, increase patient and staff satisfaction and foster new perspectives on acceptance. With their integration into clinics, a patient-centred care environment will emerge, improving patient safety, outcomes and overall well-being. Thus, the anxieties of nurses and students towards artificial intelligence technologies will decrease, and their readiness will increase.
Patient Or Public Contribution: No Patient or Public Contribution.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jocn.17562 | DOI Listing |
J Health Organ Manag
January 2025
University of Malta, Msida, Malta.
Purpose: This study explores how corporate social responsibility (CSR) and artificial intelligence (AI) can be combined in the healthcare industry during the post-COVID-19 recovery phase. The aim is to showcase how this fusion can help tackle healthcare inequalities, enhance accessibility and support long-term sustainability.
Design/methodology/approach: Adopting a viewpoint approach, the study leverages existing literature and case studies to analyze the intersection of CSR and AI.
BMC Med Inform Decis Mak
January 2025
QUEST Center for Responsible Research, Berlin Institute of Health at Charité Universitätsmedizin Berlin, Berlin, Germany.
Background: Machine learning (ML) is increasingly used to predict clinical deterioration in intensive care unit (ICU) patients through scoring systems. Although promising, such algorithms often overfit their training cohort and perform worse at new hospitals. Thus, external validation is a critical - but frequently overlooked - step to establish the reliability of predicted risk scores to translate them into clinical practice.
View Article and Find Full Text PDFBMC Emerg Med
January 2025
Emergency department, CHR Metz-Thionville, Metz, 57000, France.
Introduction: Overcrowding in emergency departments (ED) is a major public health issue, leading to increased workload and exhaustion for the teams, resulting poor outcomes. It seems interesting to be able to predict the admissions of patients in the ED.
Aim: The main objective of this study was to build and test a prediction tool for ED admissions using artificial intelligence.
J Gen Intern Med
January 2025
VA Palo Alto Cooperative Studies Program Coordinating Center, Palo Alto, CA, USA.
Background: Advances in artificial intelligence and machine learning have facilitated the creation of mortality prediction models which are increasingly used to assess quality of care and inform clinical practice. One open question is whether a hospital should utilize a mortality model trained from a diverse nationwide dataset or use a model developed primarily from their local hospital data.
Objective: To compare performance of a single-hospital, 30-day all-cause mortality model against an established national benchmark on the task of mortality prediction.
Eur J Nucl Med Mol Imaging
January 2025
Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neuro-Oncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO). Brain metastases are the most common malignant central nervous system (CNS) tumors. PET imaging with radiolabeled amino acids and to lesser extent [F]FDG has gained considerable importance in the assessment of brain metastases, especially for the differential diagnosis between recurrent metastases and treatment-related changes which remains a limitation using conventional MRI.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!